Integrated Drug Discovery Drives Intra-Biotech Acquisition
Executive Summary
Biotech, defying all predictions, has never consolidated. There are roughly as many companies today as there were three years ago, according to the Ernst & Young survey-1287 in 1996 vs. 1231 in 1993). But among leading discovery-based companies, acquisitions are beginning to be seen as a valuable business tool, though for very different reasons than consolidationists had proposed.
You may also be interested in...
Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Cosmetic And Personal Care Trademark Review 19 January, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.
Need a specific report? 1000+ reports available
Buy Reports